CRISPR Therapeutics AG

NasdaqGM:CRSP

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

Switzerland

Market Cap

USD 5.21 B

Share Price

USD 57.33

Avg Daily Volume

3,157,840

Change (1 day)

1.29%

Change (1 year)

18.89%

Change (YTD)

45.66%

CRISPR Therapeutics AG Current Assets for the year ending December 31, 2023: USD 1.91 B

CRISPR Therapeutics AG Current Assets is USD 1.91 B for the year ending December 31, 2023, a 2.97% change year over year. Current assets are assets that are expected to be converted into cash or used within one year.

CRISPR Therapeutics AG Current Assets for the year ending December 31, 2022 was USD 1.85 B, a -23.35% change year over year.
CRISPR Therapeutics AG Current Assets for the year ending December 31, 2021 was USD 2.42 B, a 40.83% change year over year.
CRISPR Therapeutics AG Current Assets for the year ending December 31, 2020 was USD 1.72 B, a 73.83% change year over year.
CRISPR Therapeutics AG Current Assets for the year ending December 31, 2019 was USD 987.55 M.